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The meta-analysis of Sahota et al. (I) suggests that 
donor leukocyte microchimerism in organ recipi-
ents is a 'real finding' that varies with the organ 
transplanted and the time of post-operative sam-
pling. and is detectable with the appropriate tech-
nology from center to center. The meta-analysis 
also reflects the lack of consensus about the signifi-
cance of microchimerism. This uncertainty has 
been perpetuated in part by incorrectly attributing 
to us the opinion that microchimerism implies free-
dom from risk of rejection and or that its presence 
or level can be used to guide drug weaning. Sahota 
et al. (I) have avoided these errors. Nevertheless. 
inaccurate citations to this effect (1) have been 
used secondarily to support the contention that the 
mechanisms of organ engraftment are different 
than those of bone marrow-induced tolerance (3-
5). 
The clinical field of organ transplantation is 
based on the fact that a host response against the 
graft. which mayor may not be strong enough to 
cause clinical and or histopathologic findings of 
rejection. is readily reversible and often is suc-
ceeded by a decline in the antigraft reactivity that 
is reflected by a reduced need for immunosuppres-
sion (6). 
TIme after TransplantatIon 
Fig. I. Contemporaneous host-versus-graft (HVGI and graft-
versus-host (GVH) reactions after transplantation. Failure is 
defined as the inability to control one of the reactions. or 
sometImes both. Acute reciprocal clonal exhaustion after suc-
cessful transplantation is maintained subsequently by 
chimerism-<iependent 10\\"grade stimulation of both leukocyte 
populations that may wa:< and wane. (By permission of New 
England journal of Medicine: 339: 1905-1913. 1998.) 
The alteration in the host-graft relationship im-
plied by these observations remained unknown un-
til it was discovered in patients with long-surviving 
organ allografts that bone marrow-derived 'pas-
senger leukocytes' migrated from the allografts to 
ubiquitous host locations and persisted for as long 
as three subsequent decades (7. 8). 
From these findings. we deduced that the 
chimerism-associated mechanisms of organ en-
graftment involved a double-immune reaction (Fig. 
I) and were the same in principle as those leading 
to tolerance following bone marrow transplanta-
tion to cytoablated recipients (7 - 9). Furthermore. 
it was emphasized that chimerism. whether at a 
'micro' or 'macro· level was only a necessary con-
dition for. but was not synonymous with. either 
allograft acceptance or tolerance. This concept has 
been strengthened by a series of experimental stud-
ies (10- 13) and has readily accommodated and 
explained observations made by its critics (14. 15). 
The host-versus-graft (HVG) reaction after ei-
ther kind of transplantation is analogous to the 
adaptive immune response to intracellular noncy-
topathic microorganisms (16-19) (Fig. 2). How-
ever. the consequences are more complex than 
those of a host versus pathogen response because 
of the countervailing graft-versus-host (GVH) re-
action mounted by mobile immunocompetent 'pas-
senger leukocytes' of the allograft (Fig. I). We 
have proposed that the HVG and GVH immune 
reactions are regulated after both organ and con-
ventional bone marrow transplantation by the mi-
gration and localization of the respective 
immunogenic leukocytes (19). 
To induce an effective response. the antigen 
must be delivered to organized lymphoid collec-
tions that are epitomized by. but not limited to. the 
lymphoid organs (18. 19). In this milieu. factors 
are present in abundance that are necessary for 
efficient immune activation (e.g. cytokines. other 
molecules. cell to cell proximity) (18). After trans-
plantation. the donor 'passenger leukocytes' leave 
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Fig. 2. Potential outcomes after infection with non-cytopathic microorganisms and analogies (expressed as rejection or graft-versus-
host disease) to organ transplantation. The horizontal axis denotes time. The vertical axis shows the magnitude of the viral load iV. 
solid line). and the host Immune response OR. dashed line). GYHD denotes graft-versus-host disease. 
the allograft. and migrate preferentially to the re-
cipient lymphoid organs (20-22). If an antigen 
primarily bypasses or secondarily avoids organized 
lymphoid collections. the immune system may re-
main or become 'indifferent" to its presence (17-
19). 
In addition to governing the initiation of the 
double-immune response. antigen migration and 
localization regulate the termination of the dual 
response (19). It is well known that the GVH 
reaction usually is the stronger one in the cytoab-
lated bone marrow recipient. whereas the domi-
nant response in the organ recipient is usually 
HVG. If either immunocyte population completely 
rejects the other. the I L2 production of the surviv-
ing leukocyte cohort ceases and its antigen-specific 
clonal expansion is terminated by apoptosis. This 
'antigen withdrawal" apoptosis requires new 
protein synthesis. is strongly inhibited by Bc 1-2 
and related anti-apoptotic molecules. and IS 
thought to involve mitochondrial apopIOsis mecha-
nisms rather than the death cytokines such as Fas 
ligand (FasLl and tumor necrosis factor (T~F) 
[summarized in (23)]. 
Alternatively. persistence of the dual sources of 
antigen may drive the double-immune reaction to 
mutual clonal exhaustion-deletion (7. 8. 19). in-
volving different molecular pathways of apoptosis 
including FasL and TNF (23). The consequence of 
this kind of apoptosis may be reciprocal antigen-
specific clonal exhaustion-deletion (2-l- 261. Al-
though the exhaustion-deletion is probably never 
absolute. it is thought to be maintained after suc-
cessful transplantation in a d~ namic but poten-
tially stable state by the periodic 'leakage' of 
leukocytes from non-lymphoid to lymphoid areas 
(18. 19). as has been described in an experimental 
model of diabetes (27). In tissue and organ recipi-
ents. the mobile antigen (i.e. the donor leukocyte 
microchimerism) rather than the 'fixed' parenchy-
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mal cells of a graft is essential for the maintenance 
of tolerance (13). If the MHC-restricted HVG re-
action to a transplanted organ is not terminated 
either by the induction of donor-specific tolerance 
(Fig. 2A). or by rejection of the allograft (Fig. 2B 1. 
the response becomes unrelenting and results in 
chronic rejection (Fig. 2C). 
Discovery of the linkage between hema-
tolymphopoietic chimerism and organ transplanta-
tion prompted the development of a paradigm that 
has challenged multiple dogmas of transplantation 
and general immunology. while explaining previ-
ously enigmatic observations in clinical transplan-
tation (7-9. 15. 19). At a basic level. it has been 
possible for the first time to define precisely the 
meaning of 'transplantation tolerance' and the 
mechanisms by which it is achieved (i.e. clonal 
exhaustion-deletion and immune indifference) (19). 
In a therapeutic context. it is obvious why it has 
been so difficult in HLA mismatched human organ 
recipients to achieve the closely related objectives 
of drug-free tolerance and freedom from chronic 
rejection. 
[n order to avoid losing allografts to acute rejec-
tion. intense immunosuppression is administered 
during the first few post-operative weeks of the 
acute donor-specific clonal expansion set in motion 
by the migration into the host of immunostimula-
tory donor passenger leukocytes. Because donor-
specific clonal exhaustion-deletion is dependent on 
the acute clonal activation. the early post-trans-
plantation period provides the prime \vindow or' 
opportunity for tolerance induction (7. 8). While 
saving the graft from rejection. the penalty for 
eroding the seminal mechanism of tolerogenesis 
with heavy immunosuppression may be the inabil-
ity to ever stop drug treatment. Under these cir-
cumstances. chronic rejection supervenes if the 
maintenance doses are reduced below the critical 
threshold necessary to compensate for the incom-
pleteness of the original tolerance induction. 
---------- ----------------------
\Vhen it was recognized that the donor passen-
ger leukocytes of bone marrow origin were respon-
sible for organ-induced tolerance. efforts began in 
earnest to augment the natural process by the 
infusion of adjunct donor bone marrow cells (28) 
as had long been advocated empirically by 
Monaco et al. (29). However. because this has 
required the same fundamentally anti-tolerogenic 
immunosuppression as for conventional organ 
transplantation. the results have been disappoint-
ing as is apparent from the meta-analysis of Sahota 
et al (I). The low-level chimerism normally found 
in organ recipients has been increased manifold 
(28. 30. 3 I ). and has been reported in some studies 
to correlate with a higher incidence of donor-spe-
cific non-reactivity. However. discontinuance of 
immunosuppression has not been achieved. 
Finding the optimal zone between under-treat-
ment (\\'ith consequent destructive immunity, and 
o\-er-treatment (with excessive erosion of toleroge-
nesis) is the channel between Scylla and Charybdis 
that is being sought by workers in transplantation. 
The task has been made more daunting by the fact 
that the appropriate conditions. unlike those in 
inbred animal tolerance models. are never exactly 
the same in any two human recipients. It is possi-
ble that clonal exhaustion-deletion can be accom-
plished more efficiently with new agents such as 
the monoclonal antibodies that block co-stimula-
tion and therefore prevent clonal expansion at a 
\-ery early stage (32 - 34). However. the basic re-
quirement for. and mechanisms of. acquired toler-
ance will remain the same. 
Thomas E Star:! 
Noriko .Hurase 
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